|
JASN RCT finds no benefits of 3 phosphorus binding drugs on vascular calcification in predialysis CKD.. |
 |
 |
|
JASN: Active therapy did, however, significantly increase calcification of the coronary arteries and abdominal aorta (coronary: median increases of 18.1% versus 0.6%, P=0.05; abdominal aorta: median increases of 15.4% versus 3.4%, P=0.03). In conclusion, phosphate binders significantly lower serum and urinary phosphorus and attenuate progression of secondary hyperparathyroidism among patients with CKD who have normal or near-normal levels of serum phosphorus; however, they also promote the progression of vascular calcification. The safety and efficacy of phosphate binders in CKD remain uncertain.
|
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
